LUNG CANCER CONSORTIUM SINGAPORE
The Lung Cancer Consortium Singapore (LCCS) was first established to bring together the clinical and research community in advancing the diagnosis and management of thoracic cancers. The need to set up the Consortium was driven by differences in lung cancer profiles and survival outcomes observed between the East and West. LCCS was formally set up in 2007 across public hospitals, with the aim of building infrastructure to promote and support nationwide collaboration for lung cancer research. This collaboration was further extended to researchers in the Agency for Science, Technology and Research (A*STAR) in 2013, with the funding support from MOH National Medical Research Council (NMRC). Today, LCCS is broadly divided into two arms, research and education. It continues to provide an important framework for thoracic oncology research in Singapore, and also has a growing emphasis on promoting education to both physicians and the public via events and forums.